| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8956130 | EBioMedicine | 2018 | 14 Pages |
Abstract
A miRNA panel may be able to determine the prognosis of urologic tumour more effectively and compensate for the unreliability of individual miRNA in estimating prognosis. More large-scale studies are therefore required to evaluate the unbiased prognostic value of miRNAs in urologic cancer effectively.
Keywords
BCATCGACHNPreferred Reporting Items for Systematic Review and Meta-AnalysisISHIQRPRISMADFSCSSNOSqRT-PCRKCaGEORFSLNMqPCRNMIBCPSAmiRNAs95%CIAUCFFPEPCAPFsProstate specific antigenRNAribonucleic acidThe cancer genome atlasDisease free survivalRelapse free survivalProgression free survivaloverall survivalBiomarkerBioinformatics analysisstandard errorWorld Health OrganizationUrologic cancerBladder cancernon-muscle-invasive bladder cancerProstate cancerKidney cancerTripod95% confidence intervalDistant metastasisLymph nodes metastasisinterquartile rangeStageTNM stageNewcastle-Ottawa Quality Assessment ScaleROC curveReceiver operating characteristic curvethe area under the curveMicroRNAMiRNAhazard ratioodds ratiosGleason scoreREMARKIn-situ Hybridizationquantitative polymerase chain reactionquantitative real-time polymerase chain reactionprognosisChineseGene Expression OmnibusWHOGleason
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Zhicong Chen, Yonghao Zhan, Jieshan Chi, Shuyuan Guo, Xinliang Zhong, Anbang He, Jianrong Zheng, Yanqing Gong, Xuesong Li, Liqun Zhou,